Group One Trading’s Aegerion Pharmaceuticals AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-48,800
| Closed | -$145K | – | 5194 |
|
|
2016
Q3 | $145K | Buy |
48,800
+24,900
| +104% | +$43.2K | ﹤0.01% | 2693 |
|
|
2016
Q2 | $36K | Buy |
23,900
+8,800
| +58% | +$20.1K | ﹤0.01% | 3511 |
|
|
2016
Q1 | $56K | Sell |
15,100
-13,200
| -47% | -$81.8K | ﹤0.01% | 3202 |
|
|
2015
Q4 | $286K | Sell |
28,300
-6,000
| -17% | -$72.2K | ﹤0.01% | 2234 |
|
|
2015
Q3 | $466K | Buy |
34,300
+23,400
| +215% | +$417K | 0.01% | 1834 |
|
|
2015
Q2 | $207K | Sell |
10,900
-20,300
| -65% | -$439K | ﹤0.01% | 2501 |
|
|
2015
Q1 | $817K | Sell |
31,200
-1,500
| -5% | -$38.2K | 0.01% | 1237 |
|
|
2014
Q4 | $685K | Sell |
32,700
-12,300
| -27% | -$310K | 0.01% | 1321 |
|
|
2014
Q3 | $1.5M | Buy |
45,000
+11,300
| +34% | +$351K | 0.02% | 864 |
|
|
2014
Q2 | $1.08M | Sell |
33,700
-55,600
| -62% | -$2.07M | 0.02% | 1085 |
|
|
2014
Q1 | $4.12M | Buy |
89,300
+3,000
| +3% | +$176K | 0.07% | 299 |
|
|
2013
Q4 | $6.12M | Buy |
86,300
+22,900
| +36% | +$1.75M | 0.09% | 201 |
|
|
2013
Q3 | $5.43M | Sell |
63,400
-59,900
| -49% | -$5.08M | 0.1% | 194 |
|
|
2013
Q2 | $7.81M | Buy |
+123,300
| New | +$6.55M | 0.19% | 95 |
|
Group One Trading's AEGR Position: Q3 2016 in Review
Group One Trading sold out of Aegerion Pharmaceuticals (AEGR) in Q3 2016, closing a stake of 14,362 shares — an estimated $24.9K sold.
Group One Trading first reported a position in AEGR in Q2 2013 and held it in 10 quarters. The position peaked at $4.11M in Q2 2013. 58 funds tracked by Wall St. Rank hold AEGR as of Q3 2016.
- Group One Trading reported no remaining Aegerion Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
- Group One Trading sold 14,362 Aegerion Pharmaceuticals shares in Q3 2016, an estimated $24.9K.
- Group One Trading first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 10 quarters.
- Group One Trading's Aegerion Pharmaceuticals position peaked at $4.11M in Q2 2013.
- 58 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q3 2016.
Based on Group One Trading's 13F filing for Q3 2016, filed 14 Nov 2016.